TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector-Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults.

Paola Cicconi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.